Cargando…

Differential Expression of RBM5, EGFR and KRAS mRNA and protein in non-small cell lung cancer tissues

BACKGROUND: RNA binding motif 5 (RBM5) is a tumor suppressor gene that modulates apoptosis through the regulation of alternative splicing of apoptosis-related genes. This study aimed to detect RBM5 expression in non-small cell lung cancer (NSCLC) and to associate RBM5 expression with clinicopatholog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liang, Hong, Zhang, Jie, Shao, Chen, Zhao, Lijing, Xu, Wei, Sutherland, Leslie C, Wang, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3403968/ https://www.ncbi.nlm.nih.gov/pubmed/22537942 http://dx.doi.org/10.1186/1756-9966-31-36

Ejemplares similares

RBM6-RBM5 transcription-induced chimeras are differentially expressed in tumours
por: Wang, Ke, et al.
Publicado: (2007)

Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells
por: Su, Zhenzhong, et al.
Publicado: (2014)

RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5
por: Loiselle, Julie J., et al.
Publicado: (2017)

Differential expression of RBM5 and KRAS in pancreatic ductal adenocarcinoma and their association with clinicopathological features
por: PENG, JIE, et al.
Publicado: (2013)

The tumor suppressor gene RBM5 inhibits lung adenocarcinoma cell growth and induces apoptosis
por: Shao, Chen, et al.
Publicado: (2012)

EGFR and KRAS Mutations in Lung Parenchyma of Subjects With EGFR/KRAS Wild-Type Lung Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2021)

Tumor suppressor gene RBM5 delivered by attenuated Salmonella inhibits lung adenocarcinoma through diverse apoptotic signaling pathways
por: Shao, Chen, et al.
Publicado: (2013)

Splicing arrays reveal novel RBM10 targets, including SMN2 pre-mRNA
por: Sutherland, Leslie C., et al.
Publicado: (2017)

RBM5 reduces small cell lung cancer growth, increases cisplatin sensitivity and regulates key transformation-associated pathways
por: Loiselle, Julie J., et al.
Publicado: (2016)

Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells
por: Su, Zhenzhong, et al.
Publicado: (2016)

RBM10: Harmful or helpful‐many factors to consider
por: Loiselle, Julie J., et al.
Publicado: (2018)

Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer
por: Nanjo, Shigeki, et al.
Publicado: (2022)

G-Quadruplex Regulation of VEGFA mRNA Translation by RBM4
por: Niu, Kangkang, et al.
Publicado: (2022)

Rbm46 regulates mouse embryonic stem cell differentiation by targeting β-Catenin mRNA for degradation
por: Zhai, Lei, et al.
Publicado: (2017)

KRAS and EGFR mutations coexisting in lung adenocarcinoma
por: Sousa, Vitor, et al.
Publicado: (2010)

EGFR and KRAS Mutations in Patients With Adenocarcinoma of the Lung
por: Jang, Tae Won, et al.
Publicado: (2009)

Rbm24a Is Necessary for Hair Cell Development Through Regulating mRNA Stability in Zebrafish
por: Zhang, Yan, et al.
Publicado: (2020)

RBM10 Modulates Apoptosis and Influences TNF-α Gene Expression
por: Wang, Ke, et al.
Publicado: (2012)

Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
por: Rosell, Rafael, et al.
Publicado: (2023)

Retraction: Rbm46 regulates mouse embryonic stem cell differentiation by targeting β-Catenin mRNA for degradation
Publicado: (2021)

Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA
por: Zolotukhin, Andrei S., et al.
Publicado: (2009)

PIK3CA Mutations Frequently Coexist with EGFR/KRAS Mutations in Non-Small Cell Lung Cancer and Suggest Poor Prognosis in EGFR/KRAS Wildtype Subgroup
por: Wang, Lei, et al.
Publicado: (2014)

Oncogenic action of the exosome cofactor RBM7 by stabilization of CDK1 mRNA in breast cancer
por: Xi, Pei-Wen, et al.
Publicado: (2020)

KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer
por: Jaromi, Luca, et al.
Publicado: (2021)

Determination of EGFR and KRAS mutational status in Greek non-small-cell lung cancer patients
por: PAPADOPOULOU, EIRINI, et al.
Publicado: (2015)

RNA‐binding protein RBM24 represses colorectal tumourigenesis by stabilising PTEN mRNA
por: Xia, Rong Mu, et al.
Publicado: (2021)

EGFR, ALK, RET, KRAS and BRAF alterations in never-smokers with non-small cell lung cancer
por: DONG, YU, et al.
Publicado: (2016)

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
por: Tomasini, Pascale, et al.
Publicado: (2016)

Detection of EGFR and KRAS Mutation by Pyrosequencing Analysis in Cytologic Samples of Non-Small Cell Lung Cancer
por: Lee, Seung Eun, et al.
Publicado: (2016)

Expression and role of EGFR, cyclin D1 and KRAS in laryngocarcinoma tissues
por: Lin, Xinsheng, et al.
Publicado: (2019)

Post-transcriptional regulation of Rbm5 expression in undifferentiated H9c2 myoblasts
por: Loiselle, Julie J., et al.
Publicado: (2015)

PTEN expression is upregulated by a RNA-binding protein RBM38 via enhancing its mRNA stability in breast cancer
por: Zhou, Xu-Jie, et al.
Publicado: (2017)

RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer
por: Wu, Jing, et al.
Publicado: (2017)

RBM20-Mediated Pre-mRNA Splicing Has Muscle-Specificity and Differential Hormonal Responses between Muscles and in Muscle Cell Cultures
por: Maimaiti, Rexiati, et al.
Publicado: (2021)

EGFR and KRAS Mutations in the Non-Tumoral Lung. Prognosis in Patients with Adenocarcinoma
por: Chalela, Roberto, et al.
Publicado: (2019)

PPM1D phosphatase, a target of p53 and RBM38 RNA-binding protein, inhibits p53 mRNA translation via dephosphorylation of RBM38
por: Zhang, Min, et al.
Publicado: (2015)

Prognostic Role of KRAS mRNA Expression in Breast Cancer
por: Hwang, Ki-Tae, et al.
Publicado: (2019)

Non-small Cell Lung Cancer with Concomitant EGFR, KRAS, and ALK Mutation: Clinicopathologic Features of 12 Cases
por: Lee, Taebum, et al.
Publicado: (2016)

EGFR, KRAS, BRAF, PTEN, and PIK3CA mutation in plasma of small cell lung cancer patients
por: Lu, Hong-Yang, et al.
Publicado: (2018)

The Frequency of EGFR and KRAS Mutations in the Turkish Population with Non-small Cell Lung Cancer and their Response to Erlotinib Therapy
por: Demiray, A, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t2apiqmurth6543b7n39koea3d